EGF-receptor and extracellular matrix changes in mouse pulmonary carcinogenesis

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Alveologenic carcinoma is a type of lung cancer.
• Epidermal growth factor (EGF) receptor plays a role in cell growth and differentiation.
• Signal transduction pathways are crucial for cellular processes.

Purpose of the Study:

• To investigate the role of EGF receptor activity in the development of alveologenic carcinoma in Balb/c mice.
• To explore the relationship between EGF receptor levels, ras oncogene mutations, and cellular transformation.
• To understand the mechanisms underlying reduced extracellular matrix protein expression in transformed lung cells.

Main Methods:

• Immunoprecipitation of cell homogenates to quantify EGF receptor protein.
• Immunohistochemistry on urethane-induced lung tumors to assess EGF receptor expression.
• Treatment of non-transformed cell clones with phorbol dibutyrate to mimic reduced EGF receptor levels.
• Detection of mutated ras oncogene in cell lines.
• Analysis of fibronectin and laminin expression.

Main Results:

• Malignant lung cell clones exhibited significantly lower EGF receptor activity and protein levels compared to nonmalignant clones.
• Low EGF receptor levels alone did not cause neoplastic transformation.
• Long-term phorbol dibutyrate treatment mimicked reduced EGF receptor levels in non-transformed cells.
• Mutated ras oncogene was detected in transformed cell lines.
• Transformed cells showed reduced expression of fibronectin and laminin, potentially at the transcriptional level.

Conclusions:

• Reduced EGF receptor activity, reflecting decreased protein levels, is a feature of malignant lung cells in this model.
• Neoplastic transformation likely requires multiple alterations in signal transduction pathways, including EGF receptor and ras oncogene.
• Reduced expression of extracellular matrix proteins in transformed cells may be regulated transcriptionally.